bariatric surgery a pharmacy perspective
DESCRIPTION
A look at medication malabsorption and nutrient deficiencies post bariatric surgery.TRANSCRIPT
![Page 1: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/1.jpg)
BARIATRIC SURGERY: A PHARMACY PERSPECTIVE
Hassan Hammoud, PharmD Candidate 2012Thomas Jefferson University
Preceptor: Sarah Nordbeck, PharmD, BCNSPNutrition Support Services
![Page 2: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/2.jpg)
ObjectivesBy the end of this session, audience members will be
able to:
Explain the place in therapy of bariatric surgery Understand the anatomical and physiological changes
post bariatric surgery Describe nutrient deficiencies related to bariatric
surgery Recognize medication malabsorption issues as a result
of bariatric surgery Understand the role of a pharmacist post bariatric
surgery
![Page 3: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/3.jpg)
Background – Obesity Obesity has reached
epidemic proportions globally (WHO) At least 2.6 million
deaths each year as a result of obesity
Was associated with high-income countries in the past now also prevalent in low/middle-income countries
Relation between mortality and BMI
Data from Lew, EA. Ann Intern Med 1985; 103:1024.
![Page 4: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/4.jpg)
Background – Obesity Huge economic burden in the US (CDC)
Direct health costs attributable to obesity estimated at $52 billion in 1995 and $75 billion in 2003
Associated with many health risks Prevention is key Many approaches to treatment available
Dietary therapy, exercise, behavior modification, drug therapy, liposuction, surgery
![Page 5: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/5.jpg)
Roux-en-Y Gastric BypassDescription
-Small pouch is created from a section of the stomach
-Section of stomach is attached directly to the small intestine
-Large part of the stomach and duodenum are bypassed
Rationale
-New stomach pouch is too small to hold large amounts of food
-Skipping the duodenum, fat absorption is substantially reduced
Image from: http://bakerbariatrics.com/procedure.htm#roux
![Page 6: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/6.jpg)
Roux-en-Y Gastric Bypass
Image from: http://agajournals.files.wordpress.com/2011/09/ahima_bypass_figure.jpg
Pancreatic enzymes and bile acids come in contact with food at the Y-site
![Page 7: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/7.jpg)
Bariatric Surgery – Indications Reserved for patients with a BMI >40 kg/m2
OR BMI >35 kg/m2 and 1 or more significant co-
morbid conditions When less invasive methods of weight loss have
failed and the patient is at high risk for obesity-associated morbidity and mortality
Pentin PL et. al. J Fam Pract. 2005;54:633.
![Page 8: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/8.jpg)
Bariatric Surgery
Significant weight loss Improvement of co-
morbid conditions Resolution of Type II
Diabetes Improved
psychological function Improved QOL
Nutrient deficiencies
Protein malnutrition
Surgical complications
Dumping syndrome
Benefits Complications
Shikora SA, et al. Nutr Clin Pract. 2007;22(1):29-40.
![Page 9: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/9.jpg)
IronFolic AcidCyanocobalaminThiamin
Part I – Nutrient Deficiencies
![Page 10: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/10.jpg)
Sites of Nutrient Absorption - Stomach
Role in nutrient absorption Water Ethyl Alcohol Copper Iodide Fluoride Molybdenum Intrinsic Factor
Shikora SA, et al. Nutr Clin Pract. 2007;22(1):29-40. Image from : www.symptomsofstomachulcer.org
![Page 11: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/11.jpg)
Sites of Absorption – Small Intestine
Calcium, Iron, Phosphorus, Magnesium, Copper, Selenium, Thiamin, Riboflavin
B-Vitamins, Vit C, Vit A, D, E,K, Ca, Phos, Mg, Zn, Iron, Chromium, Manganese,
Molybdenum, Amino Acids
Vit C, Folate, Vit B12, Vit D, Vit K, Magnesium, Bile salts/acids
Shikora SA, et al. Nutr Clin Pract. 2007;22(1):29-40.
![Page 12: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/12.jpg)
Iron Mechanism of deficiency
Iron absorption is facilitated by gastric acid Predominantly absorbed in the duodenum and
proximal jejunum Secondary to the nutrient restriction
Manifestations Iron deficiency anemia
Prevention Multivitamin with iron and vitamin C
Treatment Ferrous sulfate 300 mg/d with vitamin C
Fe B12 B1B9
Heber D et al. J ClinEndocrinolMetab. 2010 ;95(11):4823-43
![Page 13: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/13.jpg)
Cyanocobalamin Mechanism of deficiency
B12 absorbed in terminal ileum, but requires intrinsic factor
Intrinsic factor is produced in the parietal cells of stomach
Impaired formation of intrinsic factor-vitamin B12 complexes required for absorption
Manifestations Macrocytic anemia, megaloblastosis of the bone
marrow, leukopenia, thrombocytopenia, glossitis, or neurologic derangements
Ponsky TA, et al. J Am Coll Surg. 2005;201:125.
Fe B12 B1B9
![Page 14: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/14.jpg)
Cyanocobalamin Prevention/Treatment
300-500 mcg PO Daily 1000 mcg IM monthly
Alternate option:1000 mcg IM initially, followed by 100-500mcg Q 2-4wks
500 mcg/wk nasal spray
Fe B12 B1B9
Ponsky TA, et al. J Am Coll Surg. 2005;201:125.Image from: www.empr.com/calomist/drugproduct/43/
![Page 15: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/15.jpg)
Folic Acid Mechanism of deficiency
Vitamin B12 acts as a coenzyme in converting methyltetrahydrofolate to tetrahydrofolate
Folate absorption facilitated by HCl Occurs primarily in the upper one-third of the small intestine Restrictive diet post surgery drastic reduction in dietary folate
Manifestations Macrocytic anemia, leukopenia, thrombocytopenia, glossitis, or
megaloblastic marrow Prevention
Multivitamin with 1mg of folate Treatment
Folate 1 mg/d
Fe B12 B1B9
Ponsky TA, et al. J Am Coll Surg. 2005;201:125.
![Page 16: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/16.jpg)
Thiamin Mechanism of deficiency
Thiamin preferably absorbed in the proximal portion of the small intestine
Loss of absorptive area leads to deficiency Restrictive diet post surgery drastic reduction in
dietary thiamin Manifestations
Wernicke’s encephalopathy Prevention
Multivitamin with thiamin Treatment
50 -100mg IV thiamin
Fe B12 B1B9
Decker GA et al. Am J Gastroenterol. 2007;102:2571.
![Page 17: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/17.jpg)
Other Nutritional Deficiencies Amino acids Fat soluble vitamins (A,D,E & K) Calcium Zinc Magnesium Selenium
Heber D et al. J ClinEndocrinolMetab. 2010 ;95(11):4823-43
![Page 18: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/18.jpg)
Monitoring Parameters Post Bariatric Surgery
Heber D et al. J ClinEndocrinolMetab. 2010 ;95(11):4823-43
![Page 19: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/19.jpg)
Lipitor (Atorvastatin)Glucophage (Metformin)Zoloft (Sertraline)
Part II – Medication Malabsorption
![Page 20: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/20.jpg)
Mechanisms of Medication Malabsorption
Surface area reduction for drug absorption
Decreased length of intestine and drug transit time
Changes in pH Drug dissolution in acidic vs. alkaline
environment Locations of drug transporters bypassed
Smith A et al. Am J Health Syst Pharm. 2011;68:2241.
![Page 21: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/21.jpg)
Medication Strategies Drug Pharmacokinetics may be altered
due to anatomical change Selection of appropriate nutrient salts can
improve nutrient replacement Changes in dosage forms can improve
bioavailability Avoid extended release formulations Use liquid formulations if possible
Drug delivery systems that bypass GI absorption TD, IV, SL, nasal etc…
![Page 22: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/22.jpg)
Lipitor® (Atorvastatin) Pharmacokinetic profile
Presystemic clearance via intestinal CYP 3A4 (low bioavailability 12%)
P-glycoprotein substrate Pharmacokinetic alteration post surgery
↑AUC, ↑Cmax, ↑tmax Mechanism of malabsorption
Intestinal CYP3A4 bypassed decreased presystemic metabolism increased bioavailability
Management Monitor lipids Monitor LFTs for toxicity Proper dose adjustment or use other agentsEdwards A, Ensom MH. Ann Pharmacother. 2012 ;46:130.
![Page 23: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/23.jpg)
Glucophage® (Metformin) Pharmacokinetic profile
Absorption – slowly and incompletely absorbed in duodenum
Substrate for plasma membrane monoamine transporters Pharmacokinetic alteration post surgery
↑ bioavailability, ↑Vd Mechanism of malabsorption
Primary sites of absorption bypassed active transporters up-regulated leading to increased absorption
Management Increased monitoring of blood glucose recommended Drug requirements can decrease as weight loss occurs
Miller AD, Smith KM. Am J Health Syst Pharm. 2006;63:1852.Edwards A, Ensom MH. Ann Pharmacother. 2012;46:130.
![Page 24: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/24.jpg)
Zoloft® (Sertraline) Pharmacokinetic profile
Metabolized by intestinal CYP3A4 Pharmacokinetic alteration post surgery
↓ AUC, ↓Cmax Mechanism of malabsorption
Loss of absorptive surface area greater impact vs. decreased presystemic metabolism
Management Close monitoring for psychiatric symptoms
Edwards A, Ensom MH. Ann Pharmacother. 2012;46:130.
![Page 25: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/25.jpg)
Beaumont Practices Beaumont Bariatric Surgery Program
Began in 2001 Level 1 Accredited Bariatric Center (RO) certified by the American
College of Surgeons Number of surgeries annually
~300 at Beaumont >200,000 nationally
Multidisciplinary approach Surgeons, physicians, nurses, dieticians, psychiatrists & pharmacists
Post-surgery nutritional and exercise educational programs medical follow-up psychological counseling support groups cooking and nutrition classes
![Page 26: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/26.jpg)
The Pharmacist’s Role/Clinical Pearls
Review patient’s medication regimen for appropriateness Check Prescribing Information for
medication use post bariatric surgery Recommend alternate routes of
administration Monitor for toxicity and therapeutic
efficacy Recommend appropriate nutritional
supplements Communicate closely with other
healthcare professionals
![Page 27: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/27.jpg)
Conclusion Bariatric surgery is the most effective
treatment for long-term reduction of body weight
Nutritional and metabolic complications are likely after bariatric surgery Proper counseling, monitoring, and supplementation
become essential for prevention Drug Pharmacokinetics may be altered post
surgery Not predictable Close monitoring for efficacy/toxicity is necessary
![Page 28: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/28.jpg)
Questions
![Page 29: Bariatric Surgery A Pharmacy Perspective](https://reader033.vdocument.in/reader033/viewer/2022061114/5461e2b9af7959d61d8b4a06/html5/thumbnails/29.jpg)
References Heber D, Greenway FL, Kaplan LM, et al. Endocrine and nutritional management of the
post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline.J ClinEndocrinolMetab. 2010 Nov;95(11):4823-43.
Miller AD, Smith KM. Medication and nutrient administration considerations after bariatric surgery.Am J Health Syst Pharm. 2006 Oct 1;63(19):1852-7.
Smith A, Henriksen B, Cohen A. Pharmacokinetic considerations in Roux-en-Y gastric bypass patients.Am J Health Syst Pharm. 2011 Dec 1;68(23):2241-7
Malone M. Recommended nutritional supplements for bariatric surgery patients. Ann Pharmacother. 2008 Dec;42(12):1851-8. Epub 2008 Nov 18.
Edwards A, Ensom MH. Pharmacokinetic effects of bariatric surgery. Ann Pharmacother. 2012 Jan;46(1):130-6. Epub 2011 Dec 20.
Decker GA, Swain JM, Crowell MD, et al. Gastrointestinal and nutritional complications after bariatric surgery. Am J Gastroenterol. 2007 Nov;102(11):2571-80; quiz 2581. Epub 2007 Jul 19.
Shikora SA, Kim JJ, Tarnoff ME. Nutrition and gastrointestinal complications of bariatric surgery. Nutr Clin Pract. 2007 Feb;22(1):29-40. Review.
Ponsky TA, Brody F, Pucci E. Alterations in gastrointestinal physiology after Roux-en-Y gastric bypass. J Am Coll Surg. 2005 Jul;201(1):125-31.
10 facts on obesity. World Health Organization.www.who.int/features/factfiles/obesity/en/. Published 2010. Accessed March 17, 2012.
Facts About Obesity in the United States. Centers for Disease Control and Prevention. http://www.cdc.gov/obesity/. Accessed March 17, 2012.